The Scientist

» cancer and cell & molecular biology

Most Recent

image: Roundup from Microbiology Meeting

Roundup from Microbiology Meeting

By | June 21, 2012

Some of the interesting stories researchers were discussing at this year’s American Society of Microbiology meeting in San Francisco.

0 Comments

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: Gene Patents Back in Court

Gene Patents Back in Court

By | June 19, 2012

A public interest legal group has renewed the fight against DNA patenting.

0 Comments

image: Stem Cells from Corpses

Stem Cells from Corpses

By | June 15, 2012

Researchers pull viable cells from bodies that had been dead for more than 2 weeks.

1 Comment

image: Cancer-Fighting Virus

Cancer-Fighting Virus

By | June 13, 2012

A small patient trial offers hope that cancer-killing viruses might be a viable therapy after all.

3 Comments

image: Older Dads Have Healthier Kids?

Older Dads Have Healthier Kids?

By | June 11, 2012

New research finds that older men have children and grandchildren with longer telomeres, possibly pointing to health benefits of delayed reproduction.

4 Comments

image: CT Scans Increase Risk of Cancer

CT Scans Increase Risk of Cancer

By | June 7, 2012

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

1 Comment

image: TB Vax for Bladder Cancer

TB Vax for Bladder Cancer

By | June 6, 2012

How the bacteria found in a tuberculosis vaccine can improve the outcome of bladder cancer treatment

9 Comments

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

image: $18M Grant to Be Re-reviewed

$18M Grant to Be Re-reviewed

By | June 1, 2012

A Texas cancer institute is taking a second look at the largest grant it ever awarded after concerns were raised that the proposal never received proper scientific review.

5 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech